Euro-Med Laboratories Philippines approves cash dividend declaration
Euro-Med Laboratories Philippines approved a declaration of cash dividend.
Related stories
Al Bilad Securities and Investment Reports Q3 After-Tax Loss of 137,056 Dinars
M impact | EQUITY | Oct 29, 2026, 01:21 PM UTC
EPR Properties Reports Third-Quarter Revenue of $204.1 Million
Third-quarter 2026 revenue rose 12% year over year to $204.1 million, while net income attributable to common shareholders was $94.1 million. The headline reports EPS of $1.22.
M impact | EQUITY | Oct 29, 2026, 01:21 PM UTC
Blue Owl Capital Reports Third-Quarter Growth on Higher Fee-Related Earnings
Blue Owl Capital said third-quarter growth was helped by higher fee-related earnings, with assets under management reaching a record high. It posted net income of about $20 million
M impact | EQUITY | Oct 29, 2026, 01:21 PM UTC
Sterling Infrastructure Reports Third-Quarter 2026 Revenue of $1.56B
Sterling Infrastructure reported third-quarter 2026 net income of $214.93 million and diluted EPS of $6.92. Revenue rose 127% and diluted EPS rose 133% from a year earlier.
M impact | EQUITY | Oct 29, 2026, 01:21 PM UTC
ESAF Small Finance Bank Posts ₹160 Crore Q2 FY27 Profit
The bank reported its highest-ever quarterly profit, compared with a net loss of ₹116 crore in the year-earlier quarter.
M impact | EQUITY | Oct 29, 2026, 01:21 PM UTC
Ares CEO Anticipates Further Wealth Channel Flow Growth Next Year
M impact | EQUITY | Oct 29, 2026, 01:21 PM UTC